Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
8645331
Reference Type
Book/Book Chapter
Title
Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs)
Author(s)
Zhou, J; Miners, JO
Year
2014
Is Peer Reviewed?
1
Journal
Methods in Molecular Biology
ISSN:
1064-3745
EISSN:
1940-6029
Publisher
unknown
Location
TOTOWA
Book Title
Enzyme Kinetics in Drug Metabolism: Fundamentals and Applications
Volume
1113
Page Numbers
203-228
Language
English
PMID
24523115
DOI
10.1007/978-1-62703-758-7_11
Web of Science Id
WOS:000333653000013
URL
http://
://WOS:000333653000013
Exit
Abstract
Glucuronidation, catalyzed by uridine diphosphate glucuronosyltransferases (UGTs), is an important process for the metabolism and clearance of many lipophilic chemicals, including drugs, environmental chemicals, and endogenous compounds. Glucuronidation is a bi-substrate reaction that requires the aglycone and a cofactor, UDPGA. Accumulating evidence suggests that the bi-substrate reaction follows a compulsory-order ternary mechanism. To simplify the kinetic modelling of glucuronidation reactions in vitro, UDPGA is usually added to incubations in large excess. Many factors have been shown to influence UGT activity and kinetics in vitro, and these must be accounted for in experimental design and data interpretation. Assessing drug-drug interactions (DDIs) involving UGT inhibition remains challenging. However, the increasing availability of UGT enzyme-specific substrate and inhibitor "probes" provides the prospect for more reliable reaction phenotyping and assessment of DDI potential. Although extrapolation of the in vitro intrinsic clearance of a glucuronidated drug often under-predicts in vivo clearance, careful selection of in vitro experimental conditions and inclusion of extrahepatic glucuronidation may improve the predictivity of in vitro-in vivo extrapolation (IVIVE).
Editor(s)
Tweedie, D. J.
Series
Methods in Molecular Biology
ISBN
978-1-62703-758-7
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity